01—Abstract
Summary
Summary of the 8-K filed April 29, 2025. Cited figures are marked; the original filing is the authoritative source.
Amcor plc's April 29, 2025 Form 8-K is a largely administrative filing tied to its pending acquisition of Berry Global Group, Inc. (announced November 19, 2024, with Berry to become a wholly-owned Amcor subsidiary).
It does not announce new operating results or guidance. Its purpose is to provide recast audited financial statements of Berry (Exhibit 99.1) that present Berry's Health, Hygiene & Specialties Global Nonwovens and Films (HHNF) business as discontinued operations, reflecting its spin-off and merger with Glatfelter into Magnera Corporation on November 4, 2024. Amcor needs these recast statements to satisfy certain post-closing reporting obligations.
On the recast basis, Berry's fiscal 2024 (ended September 28, 2024) net sales were $10,071 milliona, down from $10,410 million in fiscal 2023, and operating income was $886 million versus $992 million. Net income was $516 million (diluted EPS $4.38) compared with $609 million (diluted EPS $4.95). Income from continuing operations was $471 million, and the HHNF business contributed $45 million of net income from discontinued operations.
Total assets were $16.6 billionb and long-term debt was $7.5 billion (plus $810 million current), so leverage is a key consideration. Ernst & Young issued an unqualified opinion, with a critical audit matter on the UK defined benefit pension obligation of $543 million. For investors, the filing is mainly useful as a cleaner baseline of Berry's continuing business ahead of the merger, in which each Berry share converts into 7.25 Amcor ordinary shares.
Investors should note the continuing-operations decline in sales and operating income, the rise in business consolidation charges to $160 millionc, and the pending closing conditions (shareholder approvals, HSR and other regulatory clearances, and the NYSE listing and S-4 effectiveness). The filing also flags that the HHNF spin-off distribution may be taxable to Berry, though management views the resulting gain as immaterial.
02—Key points
Key Highlights
- Administrative 8-K filed to provide recast Berry Global financials supporting Amcor's post-closing reporting obligations for the pending merger; no new Amcor operating results or guidance.
- Berry's HHNF business is presented as discontinued operations following its November 4, 2024 spin-off and merger with Glatfelter (creating Magnera Corporation).
- Berry continuing-operations net sales fell to $10.07 billion in FY2024 from $10.41 billion in FY2023 (about -3.3%), and operating income declined to $886 million from $992 million.
- Net income was $516 million (diluted EPS $4.38) vs. $609 million (diluted EPS $4.95) in FY2023, with $45 million of that from discontinued operations.
- Business consolidation and other activities rose to $160 million from $78 million, reflecting ongoing plant rationalization and cost-savings initiatives expected to be fully implemented by the end of fiscal 2025.
- Berry carried $8.3 billion of total long-term debt at FY2024 year-end, with net cash interest of $425 million, a key factor in the combined company's leverage profile.
- Merger terms: each Berry share converts into 7.25 Amcor ordinary shares; a $260 million termination fee applies in specified circumstances for either party; the deal remains subject to shareholder approvals and regulatory clearances.
03—Questions
Frequently Asked Questions
Does this 8-K contain new Amcor financial results or guidance?
No. The filing is primarily a procedural disclosure that provides recast audited financial statements of Berry Global (Exhibit 99.1) to reflect the HHNF business as discontinued operations. It does not include new Amcor earnings, guidance, or forward-looking financial targets.
Why were Berry's financial statements recast?
Berry spun off and merged its HHNF business with Glatfelter on November 4, 2024, and under U.S. GAAP that business qualifies as a discontinued operation. The recast presents the historical results for continuing operations without HHNF, which Amcor needs for its post-closing reporting obligations after acquiring Berry.
How did Berry's underlying performance trend in fiscal 2024?
On a continuing-operations basis, net sales declined about 3.3% to $10.07 billion, and operating income fell about 11% to $886 million. Margin pressure came partly from higher business consolidation charges ($160 million vs. $78 million), while the HHNF business contributed $45 million of net income from discontinued operations.
What does the merger mean for Berry shareholders and what could still derail it?
Each Berry share will convert into 7.25 Amcor ordinary shares. Completion requires Berry and Amcor shareholder approvals, expiration of the HSR waiting period with no FTC or DOJ challenge, other regulatory approvals, NYSE listing of the new Amcor shares, and effectiveness of the Form S-4 (declared effective January 23, 2025). A $260 million termination fee applies in specified circumstances.
Are there tax or accounting risks highlighted in the filing?
Yes. The HHNF spin-off distribution may be a taxable transaction to Berry for U.S. federal income tax purposes, though management believes any resulting gain would be immaterial given its adjusted tax basis. The auditor also flagged the UK defined benefit pension obligation ($543 million) as a critical audit matter due to its sensitivity to discount and mortality rate assumptions.
04—Continue